印度第四大制药公司MankindPharmaLtd.(MANKIND.IN)印度IPO首日收涨31.69%,报1422.30(卢比),临近收盘时曾涨至1430.00——市值达到5728亿卢比(折合将近70亿美元),为印度2023年迄今最大IP... 快讯正文 印度第四大制药公司MankindPharmaLtd.(MANKIND.IN)印度IPO首日收涨31.69%,报1422.30(卢比),临近收盘时曾涨至1430.00...
mankindpharma.comOverview & Products Financials Founded Year1991 StageIPO | IPO Total Raised$550M Date of IPO5/9/2023 Market Cap1101.37B Stock Price2748.85 Revenue$0000 View About Mankind Mankind is a pharmaceutical company focused on developing, manufacturing, and marketing a wide range of ...
所属公司:MANKIND PHARMA LTD. 成立日期:1995-01-01 所属地:印度 简介:MANKIND PHARMA LTD. 是一家制药公司,为紧急医疗需求开发、商业化和提供药物。Mankind Pharma 致力于通过配制、开发、商业化和提供负担得起且可获得的药物来满足紧急医疗需求,从而帮助社区过上健康生活。产品包括制药、非处方药和快速消费品品牌...
Check Mankind Pharma Share Price ₹2745.00 Today: Evaluate if Mankind Pharma is Overvalued or Not, Access Valuation, Financials and Fundamental Analysis for informed investment decisions with up-to-date insights.
Mankind Pharma Enters Into Agri-Tech Segment With Launch Of Agritech “We are happy to announce our launch in the agritech domain with long-term investment plans, with an initial (Rs) 150 to (Rs) 200 crore capex infusion in the first two to three years,” Mankind Pharma Managing Director...